News & ViewsNewslettersContactBecome a Research Patient
DHRHealth Institute for Research and Development

Clinical Trial

I-SPY COVID: testing novel drugs or drug combinations to treat COVID-19

Study Status:

Not Yet Recruiting

Please contact us for more information or to learn if you are eligible to participate.

Study Purpose:

The objective of this study is to identify agents that will result in substantial improvements to the clinical condition of participants with COVID-19.

Information: 

Principal Investigator
Praveen Vijhani, MD
Sponsor
Quantum Leap Healthcare Collaborative
Type of Trial
Interventional
© 2022 DHR Health Institute for Research & Development | All Rights Reserved | Terms & Conditions | Site By: KangoMedia
chevron-down linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram